Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …

Short interfering RNAs (siRNA) are a powerful class of genetic medicines whose clinical
translation can be hindered by their suboptimal delivery properties in vivo. Here, we provide …

Rationale: Angiogenesis is a fundamental process of tumorigenesis, growth, invasion and
metastatic spread. Extracellular vesicles, especially exosomes, released by primary tumors …

Simple Summary Late-stage colorectal cancer treatment often involves chemotherapy and
radiation that can cause dose-limiting toxicity, and therefore there is great interest in …

The Epstein–Barr virus (EBV) is associated with a variety of human malignancies, including
Burkitt's lymphoma, Hodgkin's disease, nasopharyngeal carcinoma and gastric cancers …

Therapy resistance is the primary problem in treating late-stage colorectal cancer (CRC).
Claudins are frequently dysregulated in cancer, and several are being investigated as novel …

Although cancer immunotherapy has emerged as a novel cancer treatment modality, it still
suffers from low therapeutic efficacy in clinics due to the presence of a low number of …

Emerging evidence in the literature describes a physical and functional association between
the neural and skeletal systems that forms a neuro-osteogenic network. This communication …

Nanomedicine has emerged as a promising platform for disease treatment and much
progress has been achieved in the clinical translation for cancer treatment. Several types of …

Ephrin type-A receptor 2 (EphA2), a receptor tyrosine kinase, is overexpressed in human
breast cancers often linked to poor patient prognosis. Accumulating evidence demonstrates …